ArticleJournal of immunotherapy and precision oncology2024

Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies.

Jibran Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.